clinical manifestations of genetic mosaicism

108
CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM RCPA Short course in Medical Genetics and Genetic Pathology Adjunct Prof Mac Gardner Univ Otago & Northern Regional Genetics, NZ

Upload: others

Post on 30-Jun-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

CLINICAL  MANIFESTATIONS  OF GENETIC  MOSAICISM

RCPA  Short course in Medical Genetics and Genetic Pathology

Adjunct Prof Mac GardnerUniv Otago & Northern Regional Genetics, NZ

Page 2: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

This word came from the ancient Greek mouseion meaning 'place holy to the Muses‘.  This transmutated into the Latin musaeum meaning ‘decoration with small square stones‘, and the decorations may originally have been dedicated to the Muses.

In medieval Latin it was changed to musaicus/mosaicus and passed via Italian mosaicoand French mosaïque into English as mosaic. 

DERIVATION OF THE WORD ‘MOSAICISM’

Page 3: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

The starting position:

Mosaicism is common

Indeed, are we all mosaics?

Page 4: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Consider the mathematics:

A person ≈ 10,000,000,000,000 cells

This needed 9,999,999,999,999 mitoses

No QA system could get it right that many times!

Page 5: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MOSAICISM:   

2 or more genetically different cell lineages in the constitution of one individual, derived from a single original zygote    (one cell 

line usually normal)

Mendelian:  Some cells/tissues carry a classic gene mutation

Chromosomal: 2 (or more) karyotypically different cell lines*:

Epigenetic:  Some cells/tissues have a different imprinting state (cf. David Amor re somatic UPD11)

Immunogenetic:  All that rearranging of immunogenes

CNVs: May be rather frequent

Mitochondrial: The whole question of heteroplasmy

* k i l id

Page 6: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

Cancer:

Many/practically all cancers are chromosomally ‘mosaic’, but these arise post‐constitutionally in 46,XY and 46,XX people (a.k.a. normal men and women)

Example of highly complex cytogenetic aberrations in a case of high‐grade myxofibrosarcoma 

Willems SM, Debiec‐Rychter M, Szuhai K, Hogendoorn PC, Sciot R. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol. 2006 Mar;19(3):407‐16.

Page 7: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

Chromosomal loss with ageing: 

• The quite common finding of loss of an X or a Y chromosome in an occasional cell in an older female or male population (and more notably in centenarians) may reflect “normal” age‐related anaphase lag. 

Page 8: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

X Chromosome inactivation in females: 

• Every 46,XX female is mosaic with respect to X chromosome activation

• An epigenetic form of mosaicism

• Each cell makes its own autonomous decision about which X  – maternal or paternal  – remains the active one, at a very early stage of embryonic existence

Page 9: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

X Chromosome inactivation in females: 

• Every 46,XX female is mosaic with respect to X chromosome activation

• An epigenetic form of mosaicism

• Each cell makes its own autonomous decision about which X  – maternal or paternal  – remains the active one, at a very early stage of embryonic existence

Page 10: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

Chimerism: 

The existence of 2 cell lines of different origins: 

(1)     Fusion of 2 DZ twin embryos

(2)     Iatrogenic engraftment

(3)     Maternal residuum of fetal cells post partum, 46,XX//46,XY:  A cause of maternal auto‐immune disease (systemic                   sclerosis/scleroderma)

Rak JM, et al.  Male  microchimerism and HLA compatibility  in French women  with sclerodema: a different profile in limited and diffuse  subset. Rheumatology 2009 48(4):363‐6.

Page 11: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Excluding:

Chimerism: 

The existence of 2 cell lines of different origins: 

(1)     Fusion of 2 DZ twin embryos

(2)     Iatrogenic engraftment

(3)     Maternal residuum of fetal cells post partum, 46,XX//46,XY:  A cause of maternal auto‐immune disease (systemic                   sclerosis/scleroderma)

Rak JM, et al.  Male  microchimerism and HLA compatibility  in French women  with sclerodema: a different profile in limited and diffuse  subset. Rheumatology 2009 48(4):363‐6.

Page 12: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MOSAICISM CAN BE:

• SOMATIC,

• GONADAL,  or

• SOMATIC‐GONADAL

and

• MENDELIAN, or

• CHROMOSOMAL

Distribution

Genetic type

Page 13: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MENDELIAN SOMATIC MOSAICISM:

The genetic error arises 

• post‐zygotically,  after initial differentiation of embryonic cell types

• in a cell destined to form a body lineage other than gonadal tissue.

Four examples:

• Neurofibromatosis type 1 (gene is neurofibromin)

• Neurofibromatosis type 2 (gene is NF2, a.k.a. merlin)

• Periventricular nodular heterotopia (one gene is  FLNA)

• Atrial fibrillation (one gene may be GJA5)

Page 14: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

NF1, a.k.a. VON RECKLINGHAUSEN’S DISEASE

Somatic mosaicism, also called ‘segmental’ mosaicism

Cutaneous signs confined to one region of the body

Page 15: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet. 2000 8:455-9.

Page 16: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet. 2000 8:455-9.

Page 17: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

NF1, a.k.a. VON RECKLINGHAUSEN’S DISEASE

Somatic mosaicism, also called ‘segmental’ mosaicism

Cutaneous signs confined to one region of the body

Skin fibroblasts from café au lait macule deletion of the NF1 gene

Fibroblasts from skin elsewhere, and blood, normal

Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet. 2000 8:455-9.

Page 18: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Mutation happened in this cell?

Page 19: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Cardiac tube

Mutation happened in this cell?

What he (and we) looked like at 3 weeks of age:

Page 20: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

• 29 y/o female, quite sudden onset lower limb weakness and loss of bladder control

• Hearing grossly intact  

• MRI showed spinal and intracranial tumours:

Neurofibromatosis type 2  (NF2)

a.k.a. Bilateral Vestibular Schwannoma

Page 21: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Tumour

Post-opPre-op

Schwannoma

Page 22: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Vestibular schwannoma

Page 23: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Question:

Will our children get this? What if we have another child?

NF2

Page 24: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 25: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

NF2 and the neural crest ...

Page 26: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

and Schwann cells

Page 27: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

What she (and we) looked like at 3 weeks of age:

Cardiac tube

Neural tube

Page 28: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

Neural

tube

At day 20 of life: genetically perfect

Page 29: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

At day 21 of life: one (somatic) cell mutates

Page 30: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

“First hit”

Page 31: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

“First hit”

Page 32: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Page 33: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Cell can cross the midline

Page 34: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Purple cell = cell having “second hit”

Page 35: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Purple, blue cells = cells having “second hits”

Page 36: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Purple, blue, red = cells having “second hits”

Page 37: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Orange cells = progeny cells from “first hit”

Purple, blue, red = cells having “second hits”, whose progeny, being homozygous (or cpd het), can form aschwannoma

Page 38: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

(Hypothetical) first & second hits at molecular level

gln320stop448 –1 g>a

methylation

Page 39: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

How this knowledge, along with a basic understanding of embryology, can inform genetic counselling .....

Page 40: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

Precursor yolk sac cells, which will ⇒blood, gametocytes

Page 41: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

BILATERAL TUMOURS

Precursor yolk sac cells, which will ⇒gametocytes

Page 42: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

BILATERAL TUMOURS

Precursor yolk sac cells, which will ⇒gametocytes

Blood cells

Page 43: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Neural crest cells

UNILATERAL TUMOURS

Precursor yolk sac cells, which will ⇒gametocytes

Page 44: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MINIMUM ESTIMATES OF MOSAICISM IN SPORADIC (-ve fam hx) CASES OF NF2

Bilateral vestib schwannoma: 33% +

Unilat “ “ : 60% +

But what fraction of the mosaicism includes the gonad?

Page 45: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Transmission risks to offspring for isolated cases of NF2,  after negative mutation testing on peripheral blood

Age at dx       Risk  (cf. baseline risk = 50% in nonmosaic)____________________________________

VESTIBULAR SCHWANNOMA IS

____________BILAT________UNILAT____

< 20      30%          11% 20–29    16%  8%30–39    11%  6%40+ 9% 5%____________________________________

Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation‐dependent probe amplification. D Gareth R Evans, R T Ramsden, A Shenton, C Gokhale, N L Bowers, S M Huson, G Pichert, A Wallace J. Med. Genet. 2007;44;424‐428.

Neurofibromatosis type 2 (NF2): a clinical and molecular review. Evans DGR. Orphanet J Rare Dis. 2009 19:16.

Page 46: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

N.

Question:

Will our children get this? What if we have another child?

Answer:

Probably, no

NF2

Page 47: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

• Periventricular nodular heterotopia ‐‐ a cause of epilepsy in females

Might some, mutation‐negative on blood, be due to localised (periventricular neurone) mutation in FLNA (filamin‐A)?

• Atrial fibrillation

Some may be due to localised (cardiac myocyte) mutation in ‘gap junction protein’ gene GJA5 (connexin‐40)

Gollob MH et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. New Engl J Med 354: 2677-2688, 2006.

Page 48: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Immune dysfunction Adenosine deaminase deficiencyWiskott–Aldrich syndrome

Clotting disordersHaemophilia AHaemophilia B

Skeletal disorders AchondroplasiaOsteogenesis imperfectaMarfan syndromePseudoachondroplasia

Muscle disorders Duchenne muscular dystrophyCongenital myotonic dystrophy

Chromosomal instability Bloom syndromeFanconi anaemia

Tumour suppressor Neurofibromatosis type INeurofibromatosis type IITuberous sclerosis

Skin disorders Bullous ichthysiform erythrodermaIncontinentia pigmenti

Endocrine disorders Androgen insensitivity

Nervous-system Friedreich ataxia

Metabolic disordersTyrosinaemia type ILesch–Nyhan

Youssoufian & Pyeritz 2002

Recognition of somatic mosaicism: representative monogenic disorders

Page 49: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

How much rare variation?

“The total somatic mutational load must be enormous. For example, theintestinal epithelium contains approximately 106 independent stem cells,each of which generates transient daughter cells every week or two. Thus,the intestinal epithelium of a 60-y-old is expected to harbor >109

independent mutations. This implies that, not far beyond the age of60y, nearly every genomic site is likely to have acquired a mutation inat least one cell in this single organ.”

Page 50: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC ‘REVERTANT’ MOSAICISM OF LATER ORIGIN

The genetic ‘correction’ arises 

• post‐zygotically

• well into embryonic/fetal development

• in a differentiated cell, destined to form just one body lineage

One example:

• Epidermolysis bullosa ‐‐ a blistering/dystrophic skin disorder

Page 51: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 52: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC ‘MOSAICISM’ OF VERY EARLY ORIGIN:MZ TWIN DISCORDANCE

The genetic error arises 

• post‐zygotically

• at or before the blastocyst/inner cell mass stage

• after splitting of embryo into 2

• in a cell destined to form all or almost all body lineages

Three examples:

• Dravet syndrome of severe epilepsy  (gene is  sodium channel SCN1A)

• NF1  (gene is neurofibromin)

• Trisomy 21 (may be ‘correction’, rather than an error)

Mendelian

Chromosomal

Page 53: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

Page 54: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

Page 55: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Twin with epilepsy →

(Dravet syndrome)

SCN1A mutation in all these tested tissues

← Unaffected twin

Normal SCN1A gene in all these tested tissues

Timing of de novo mutagenesis‐‐a twin study of sodium‐channel mutations. Vadlamudi L, Dibbens LM, Lawrence KM, Iona X, McMahon JM, Murrell W, Mackay‐Sim A, Scheffer IE, Berkovic SF. N Engl J Med 2010 363:1335‐40.

Page 56: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

Normal allele mutates to an SCN1A allele

Zygote is normal at SCN1A locus

ONE TWIN WITH DRAVET SYNDROME

Page 57: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation.

Vogt J, Kohlhase J, Morlot S, Kluwe L, Mautner VF, Cooper DN, Kehrer-Sawatzki H. Institute of Human Genetics, University of Ulm, Ulm, Germany.

“Whereas DNA sequence analysis indicated somatic mosaicism for the NF1 nonsense mutation, c.4108C>T (p.Q1370X), in the affected twin, this lesion was apparently absent in his unaffected brother. . . . . .

We conclude that the twinning event, which would have taken place within three days post-fertilization, must have preceded the c.4108C>T mutation which is therefore predicted to have occurred during the blastocyst stage, leading to somatic mosaicism with normal cells lacking the mutation.”

Page 58: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

Zygote is normal at NF1 locus

Twining occurs by day 3-4 morula/blastocyst

ONE TWIN WITH NF1

Page 59: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Jansen RPS, Bowman MC, de Boer KA, Leigh DA, Lieberman DB, McArthur SJ. What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod 23: 1476-1478, 2008.

Hatching blastocyst →

Hatched blastocyst →

Page 60: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

Normal allele mutates to an NF1 allele, in one cell of day 4 or 5 blastocyst

Zygote is normal at NF1 locus

Twining occurs by day 3-4 morula/blastocyst

ONE TWIN WITH NF1

Page 61: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

MZ

‘Third’ chromo 21 lostZygote is

trisomy 21

ONE TWIN WITH TRISOMY 21

47,XX,+21 46,XX

Page 62: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC MOSAICISM  IN THE EARLY EMBRYO ~ CHROMOSOMAL

The genetic error arises 

• post‐zygotically, 

• in 1 or more cells in a preimplantation embryo

Four examples:

• Trisomy 21 mosaicism – a classic e.g.     (As above, but didn’t twin)

• The concept of ‘chaotic mosaicism’ in the IVF embryo (but in vivo?)

• Fetal Trisomy 3

• ‘Hypomelanosis of Ito’ associated with mosaicism for a structural   rearrangement

Page 63: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC MOSAICISM  IN THE EARLY EMBRYO ~ CHROMOSOMAL

The genetic error arises 

• post‐zygotically, 

• in 1 or more cells in a preimplantation embryo

Four examples:

• Trisomy 21 mosaicism – a classic e.g.     (As above, but didn’t twin)

• The concept of ‘chaotic mosaicism’ in the IVF embryo (but in vivo?)

• Fetal Trisomy 3

• ‘Hypomelanosis of Ito’ associated with mosaicism for a structural   rearrangement

Page 64: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

PGD -- Preimplantation Genetic Diagnosis

Page 65: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

biopsiedblastomere

‘Chaotic mosiaicism’ in a day-3 embryo

Studied blastomeres

Hypothetical derivative

−3+5+13+14+18−19+20+22+X+Y-

+1+3−18+X+Y

3

1,18,X,Y

−1+3+18−X−Y

lysed blastomere

Courtesy: Lucille Voullaire

Page 66: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 67: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

+3−3

Page 68: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

+3−3

N

Page 69: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

+3−3

N

To the placenta: ‘confined placental mosaicism’

Page 70: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

+3−3

N

To the inner cell mass: true mosaicism of the embryo

Page 71: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC MOSAICISM  IN THE EARLY EMBRYO ~ CHROMOSOMAL

The genetic error arises 

• post‐zygotically, 

• in 1 or more cells in a preimplantation embryo

Four examples:

• Trisomy 21 mosaicism – a classic e.g.     (As above, but didn’t twin)

• The concept of ‘chaotic mosaicism’ in the IVF embryo (but in vivo?)

• Fetal mosaic Trisomy 3  (majority of cells trisomic)

• ‘Hypomelanosis of Ito’ associated with mosaicism for a structural   rearrangement

Page 72: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

FETAL mosaic TRISOMY 3

Page 73: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

FETAL mosaic TRISOMY 3

Page 74: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

FETAL TRISOMY 3

Page 75: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 76: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC MOSAICISM  IN THE EARLY EMBRYO ~ CHROMOSOMAL

The genetic error arises 

• post‐zygotically, 

• in 1 or more cells in a preimplantation embryo

Four examples:

• Trisomy 21 mosaicism – a classic e.g.     (As above, but didn’t twin)

• The concept of ‘chaotic mosaicism’ in the IVF embryo (but in vivo?)

• Fetal mosaic Trisomy 3  (majority of cells trisomic)

• ‘Hypomelanosis of Ito’ associated with mosaicism for a structural   rearrangement

Page 77: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Mosaicism for a duplication of terminal 3q: 3q26.3→3qter

HYPOMELANOSIS OF ITO

Page 78: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

SOMATIC‐GONADAL MOSAICISM ~ CHROMOSOMAL

The genetic error arises 

• post‐zygotically, 

• in a cell destined to form somatic and gonadal tissue.

One example:

• Parental low‐level mosaicism for a deletion of chromosome 1q

Page 79: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

blood

Page 80: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

GONADAL MOSAICISM

The genetic error arises 

• post‐zygotically, 

• in a mitotic (pre‐meiotic) gametocyte

• Consider the seminiferous tubule total length of 1 km . . . . 

Page 81: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

1,000/1,000,000,000 = 1 millionth of the tubule has this abnormality

Page 82: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Close to 1 km of tram track in view

A small ($2) coin comprises 1/50,000 of the distance.

Page 83: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

GONADAL MOSAICISM ~ CHROMOSOMAL

One example:

• Parental low‐level mosaicism for a duplication  ‐‐ dup(21)

Page 84: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

mos dup(21)

• Couple, 3 previous miscarriages, 2 previous failed IVF cycles

• IVF/PGD using FISH, 13 embryos, 2 transfers, 0 pregnancies

• Of 13 embryos, 4 showed apparent dup(21)(q22)

• Of 1002 sperm, 66 showed the same apparent dup(21)

Somprasit et al., RBM Online 9, 225,

Page 85: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Cell from embryo Sperm cells

Reprod Biomed Online 9, 225, 2004

Page 86: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

4

26

Page 87: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

6% of the track between here and the tram

Page 88: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

GONADAL MOSAICISM ~ MENDELIAN:

Two examples:

• Duchenne muscular dystrophy (gene is dystrophin)

• Achondroplasia (gene is FGFR3)

Page 89: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Gonadal mosaicism for Duchenne muscular dystrophy (gene is dystrophin)

Melis MA, Cau M, Congiu R, Puddu R, Muntoni F, Cao A. Germinal mosaicism in a Duchenne muscular dystrophy family: implications for genetic counselling. Clin Genet. 1993 43:247-9.

Page 90: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Natacci F, Baffico M, Cavallari U, Bedeschi MF, Mura I, Paffoni A, Setti PL, Baldi M, Lalatta F. Germline mosaicism in achondroplasia detected in sperm DNA of the father of three affected sibs. Am J Med Genet 2008 146A:784-6.

Gonadal mosaicism for achondroplasia (gene is FGFR3)

Peripheral blood:

Sperm:

Page 91: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

PATHOGENIC MOSAICISM CAN BE:

• SOMATIC

e.g. Segmental NF1, Hypomelanosis of Ito

• overtly SOMATIC‐GONADAL

e.g. Father carries deleted no. 1 chromosome 

• GONADAL

e.g. grandfather carries Duchenne, father carries abn chromosome 21

Page 92: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

END

Page 93: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 94: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 95: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Arvid Lindau (1892 – 1958), a Swedish pathologist, who described the link between the retinal, cerebellar and visceral components of a disease, which he called “angiomatosis of the central nervous system”. 

Eugen von Hippel (1867 ‐ 1939), a German ophthalmologist, first described “angiomatosis retinae” in 1911.

Page 96: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

VHL ? Somatic mosaic

• 49 y/o man, onset giddiness, ataxia, vomiting  loss of consciousness

• MRI  cerebellar tumour

• Histo confirms haemangioblastoma

• Second small lesion in R cerebellar hemisphere

• Renal and pancreatic cysts

Page 97: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Cerebellar haemangioblastoma

Page 98: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 99: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 100: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM
Page 101: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

P

Page 102: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

• No retinal angiomas 

• MRI r/v  normal adrenal, inner ear anatomy

• Plasma metanephrine normal

Page 103: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

VHL:

• Cerebellar/spinal hemangioblastoma      

• Retinal angioma     

• Pheochromocytoma (incl. extra‐adrenal)   

• Renal cancer   

• Renal cysts   

• Pancreatic cysts   

• Epididymal cysts    

• Endolymphatic sac tumour    

• +ve family hx  

Page 104: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

• But: on VHL gene sequencing no mutation;  andon MLPA, no large deletion/duplication

Note:  gene testing has high (97%) detection rate

Page 105: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Why no mutation found? 

Possible explanations:

• A VHL‐like ‘phenocopy’  ?

• True VHL, mutation not able to be detected  ?

• Somatic (or somatic‐gonadal) mosaicism  ? 

…… distinction important, in order to be able to advise son

Page 106: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Youssoufian & Pyeritz 2002

a | Asymmetric fibrous dysplasia (non-neoplastic developmental disease of osseous tissue) of bones and irregular skin hyperpigmentation in a female with MCCUNE–ALBRIGHT SYNDROME101. (Reproduced with permission from REF. 131 © (1993) Oxford University Press).

Page 107: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

*

b | Regenerating liver nodules (asterisk) that have a reversion of an inherited mutation in the fumarylacetoacetate hydrolase gene, which causes HEREDITARY TYROSINAEMIA TYPE I.(Reproduced with permission from REF. 22 © (1998) Elsevier Science (USA)

Youssoufian & Pyeritz 2002

Page 108: CLINICAL MANIFESTATIONS OF GENETIC MOSAICISM

Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum DisorderKavita S Reddy Genzyme Genetics, Orange CA 92868, USAauthor email corresponding author email

BMC Medical Genetics 2005, 6:3J Med Genet. 1996 Apr;33(4):338-40.Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene.Milà M, Castellví-Bel S, Sánchez A, Lázaro C, Villa M, Estivill X.